Least Developed Countries (LDCs) vs Saudi Arabia: Proportion of the target population … measles-containing-vaccine
Least Developed Countries (LDCs)
58.0%
in 2024
Saudi Arabia
96.0%
in 2024
Least Developed Countries (LDCs) rank
31st
Saudi Arabia rank
28th
Proportion of the target population … measles-containing-vaccine over time
- Least Developed Countries (LDCs)
- Saudi Arabia
How they compare
Saudi Arabia currently reports 96.0% against 58.0% in Least Developed Countries (LDCs), a difference of 38.0%.
That makes Saudi Arabia's figure about 1.7 times Least Developed Countries (LDCs)'s.
Across all 24 years both countries report, Saudi Arabia has been ahead every year.
Least Developed Countries (LDCs) ranks 31st and Saudi Arabia ranks 28th of 36 groups.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Least Developed Countries (LDCs) | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.4% | 97.1% | 95.7% | Saudi Arabia |
| 2010s | 24.6% | 97.1% | 72.5% | Saudi Arabia |
| 2020s | 48.6% | 96.6% | 48.0% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Least Developed Countries (LDCs) or Saudi Arabia?
- Saudi Arabia, at 96.0% against 58.0% in Least Developed Countries (LDCs) as of 2024.
- What is the difference in proportion of the target population who received between Least Developed Countries (LDCs) and Saudi Arabia?
- 38.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Least Developed Countries (LDCs) and Saudi Arabia?
- 24 years are reported by both, from 2001 to 2024.
- How do Least Developed Countries (LDCs) and Saudi Arabia rank globally for proportion of the target population who received?
- Least Developed Countries (LDCs) ranks 31st and Saudi Arabia ranks 28th of 36 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.